Literature DB >> 34424510

Viability assessment of Mycobacterium tuberculosis complex in OMNIgene • SPUTUM reagent using the BACTEC MGIT 960 System and Xpert MTB/RIF assay.

Akemi Oshiro Guirelli1, Andréia Moreira Dos Santos Carmo1, André Eterovic2, Lucilaine Ferrazoli3, Vilma Dos Santos Menezes Gaiotto Daros1, Maria Cecilia Cergole-Novella4.   

Abstract

The World Health Organization advocates that sputum specimens submitted to tuberculosis (TB) diagnostic should be processed within 48 h after collection and be stored under cooling. We aimed to assess the performance of OMNIgene • SPUTUM reagent in maintaining viable specimens of Mycobacterium tuberculosis complex (MTBC) during transportation of sputum samples without refrigeration, in comparison to the standard protocol of the National TB Control Program. Sputum samples obtained in southeastern Brazil (June 2017 to July 2018) from 100 sequential patients with positive acid-fast bacillus smear microscopy were divided into two portions. Portion 1 continued to be cooled (standard protocol, STA), but portion 2 was added to OMNIgene • SPUTUM reagent (alternative protocol, OMS) until concomitant further processing. Both portions of all samples were cultured using MGIT and tested by Xpert MTB/RIF assay. Growth of MTBC in the first 42 days was detected in 96% of the cultures under the STA and 88% under the OMS. Intervals between processing and detecting MTBC growth in the two portions significantly differed (p = 0.0001). Portions under the two protocols showed similar results in the MTBC detection by Xpert assay and culture contamination by non-MTBC. The OMNIgene reagent liquefies and decontaminates sputum leading to a decrease in processing time. Although there was a small delay in mycobacterial growth, the OMNIgene reagent can be useful in specimens transported from collection sites over a long distance to centralized testing centers, maintaining viable MTBC for at least 8 days at room temperature.
© 2021. Sociedade Brasileira de Microbiologia.

Entities:  

Keywords:  BACTEC MGIT; OMNIgene • SPUTUM; Sputum transport; Tuberculosis; Xpert MTB/RIF

Mesh:

Substances:

Year:  2021        PMID: 34424510      PMCID: PMC8578262          DOI: 10.1007/s42770-021-00568-2

Source DB:  PubMed          Journal:  Braz J Microbiol        ISSN: 1517-8382            Impact factor:   2.214


  10 in total

Review 1.  Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance.

Authors:  Stephen D Lawn; Mark P Nicol
Journal:  Future Microbiol       Date:  2011-09       Impact factor: 3.165

2.  Evaluation of OMNIgene Sputum and Ethanol Reagent for Preservation of Sputum Prior to Xpert and Culture Testing in Uganda.

Authors:  Elisa Ardizzoni; Patrick Orikiriza; Charles Ssuuna; Dan Nyehangane; Mourad Gumsboga; Ivan Mugisha Taremwa; Esther Turyashemererwa; Juliet Mwanga-Amumpaire; Céline Langendorf; Maryline Bonnet
Journal:  J Clin Microbiol       Date:  2019-12-23       Impact factor: 5.948

3.  Commercial products to preserve specimens for tuberculosis diagnosis: a systematic review.

Authors:  B W P Reeve; S M McFall; R Song; R Warren; K R Steingart; G Theron
Journal:  Int J Tuberc Lung Dis       Date:  2018-07-01       Impact factor: 2.373

4.  OMNIgene SPUTUM: A good transport and decontaminating reagent for tuberculosis testing.

Authors:  Diana Asema Asandem; Adwoa Asante-Poku; Prince Asare; Sammy Yaw Aboagye; Osei-Wusu Stephen; Emelia Danso; Pius Mawutor Klevor; Kenneth Mawuta Hayibor; Dorothy Yeboah-Manu
Journal:  Int J Mycobacteriol       Date:  2018 Jul-Sep

5.  Novel multi-day sputum transport reagent works with routine tuberculosis tests and eliminates need for cold chain: Preliminary study of compatibility with the Xpert® MTB/RIF assay.

Authors:  Cassandra D Kelly-Cirino; Patricia S Curry; Jamie L Marola; Niels K Helstrom; Max Salfinger
Journal:  Diagn Microbiol Infect Dis       Date:  2016-08-16       Impact factor: 2.803

6.  Molecular typing and differentiation of Mycobacterium tuberculosis clinical isolates using Double Repetitive Element PCR and Duplex PCR.

Authors:  Kathirvel Maruthai; Thirumurugan Ravibalan; Kommoju Vallayyachari; Surendar Kesavan; Antony V Samrot; Muthuraj Muthaiah
Journal:  Int J Mycobacteriol       Date:  2015-01-13

7.  Comparative study of OMNIgene®•SPUTUM reagent versus cold-chain for the transportation of sputum samples to GeneXpert®MTB/RIF testing sites in Malawi.

Authors:  Wondwossen A Alemayehu; S Neri; S Dalebout; R Nalikungwi; A Trusov; E Ahmed; A Dimba; A Weirich; P S Curry; C D Kelly-Cirino
Journal:  BMC Infect Dis       Date:  2019-05-16       Impact factor: 3.090

8.  Time to culture positivity and sputum smear microscopy during tuberculosis therapy.

Authors:  Ioana D Olaru; Jan Heyckendorf; Susanne Grossmann; Christoph Lange
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

9.  Evaluation of Mycobacterium tuberculosis viability in OMNIgene-SPUTUM reagent upon multi-day transport at ambient temperature.

Authors:  Elisa Tagliani; Riccardo Alagna; Silva Tafaj; Hasan Hafizi; Daniela Maria Cirillo
Journal:  BMC Infect Dis       Date:  2017-10-02       Impact factor: 3.090

10.  A novel sputum transport solution eliminates cold chain and supports routine tuberculosis testing in Nepal.

Authors:  Bhagwan Maharjan; Bhabana Shrestha; Alexandra Weirich; Andrew Stewart; Cassandra D Kelly-Cirino
Journal:  J Epidemiol Glob Health       Date:  2016-04-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.